Peer Review reports
From: Speckle-type POZ protein could play a potential inhibitory role in human renal cell carcinoma
| Original Submission | ||
|---|---|---|
| 14 Aug 2022 | Submitted | Original manuscript |
| 30 Sep 2022 | Reviewed | Reviewer Report - Yohei Sekino |
| 3 Oct 2022 | Reviewed | Reviewer Report |
| 20 Oct 2022 | Author responded | Author comments - Wei Li |
| Resubmission - Version 2 | ||
| 20 Oct 2022 | Submitted | Manuscript version 2 |
| 21 Oct 2022 | Author responded | Author comments - Wei Li |
| Resubmission - Version 3 | ||
| 21 Oct 2022 | Submitted | Manuscript version 3 |
| 25 Oct 2022 | Author responded | Author comments - Wei Li |
| Resubmission - Version 4 | ||
| 25 Oct 2022 | Submitted | Manuscript version 4 |
| 31 Oct 2022 | Reviewed | Reviewer Report - Yohei Sekino |
| 8 Nov 2022 | Reviewed | Reviewer Report |
| 13 Nov 2022 | Author responded | Author comments - Wei Li |
| Resubmission - Version 5 | ||
| 13 Nov 2022 | Submitted | Manuscript version 5 |
| 15 Nov 2022 | Author responded | Author comments - Wei Li |
| Resubmission - Version 6 | ||
| 15 Nov 2022 | Submitted | Manuscript version 6 |
| 18 Nov 2022 | Reviewed | Reviewer Report |
| Resubmission - Version 7 | ||
| Submitted | Manuscript version 7 | |
| Publishing | ||
| 21 Nov 2022 | Editorially accepted | |
| 7 Dec 2022 | Article published | 10.1186/s12885-022-10340-w |
You can find further information about peer review here.